Prelude Therapeutics lands $60 million in Series B funding - Technical.ly Delaware

Sciences

Jun. 26, 2019 1:42 pm

Prelude Therapeutics lands $60 million in Series B funding

The company plans to enter preclinical development on its cancer drug therapies this year.
Biotechnology continues to grow in Delaware.

Biotechnology continues to grow in Delaware.

(Photo by Pexels user Martin Lopez used under a Creative Commons license)

Wilmington-based Prelude Therapeutics, a biotech startup that launched in 2016, has secured $60 million in Series B financing, DelawareBio has reported.

The financing was co-led by Prelude’s two existing institutional investors, including OrbiMed Advisors LLC, bringing Prelude’s total investments to date to $95 million.

Prelude is a clinical-stage biopharmaceutical company. Several of its drug discovery programs are expected to enter preclinical development this year, with a potential IND (Investigational New Drug) filing in 2020.

“We are very appreciative of the continued support of our current investors, who have been integral to the founding of Prelude and the creation of our growing pipeline,” said Kris Vaddi, PhD, Founder and CEO of Prelude Therapeutics, in a press release. “We believe PRMT5 inhibitors represent a promising new class of drugs to treat cancers, including ones that have developed resistance to existing targeted therapies. We are also pleased to have assembled such a talented, experienced and proven leadership team to address some of the most pressing gaps in cancer treatment.”

Dr. Vaddi was previously a member of the founding team of Incyte Corporation in 2002. He initiated JAK (Janus kinase, enzymes that have been discovered to play role in the body’s immune defense) research programs at Incyte that led to Jakafi (ruxolotinib) for myelofibrosis and polycythemia vera and Olumiant (Baricitinib) for rheumatoid arthritis.

-30-
CONTRIBUTE TO THE
JOURNALISM FUND

Already a contributor? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

‘Stop asking for permission’ and other advice from women making a difference

Delaware State University leads biopharma talent development project

UD-led program receives $23.5M for biomed research

SPONSORED

Delaware

These hiring companies want to meet you at NET/WORK Suburbs

Philadelphia, PA

Vistar Media

QA Engineer

Apply Now

Philadelphia

Vistar Media

Sr. Software Engineer

Apply Now

Philadelphia

Vistar Media

Front End Engineer

Apply Now

Here’s a peek at TheraV’s upcoming series ‘Amputee Wisdom’

FMC is investing $50 million into its Newark agtech research facility

How this UD makerspace is innovating the future of wearables

SPONSORED

Delaware

Mastering the ‘halo effect’ in tech recruiting

Malvern, PA

Vanguard

Full Stack Software Engineer – SRE

Apply Now

Malvern, PA

Vanguard

Senior Cloud Operations Engineer – AWS

Apply Now

Malvern, PA

Vanguard

Mobility & UEM Engineer – Workspace ONE

Apply Now

Sign-up for daily news updates from Technical.ly Delaware

Do NOT follow this link or you will be banned from the site!